These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9425641)

  • 41. Nasal interleukin-5, immunoglobulin E, eosinophilic cationic protein, and soluble intercellular adhesion molecule-1 in chronic sinusitis, allergic rhinitis, and nasal polyposis.
    Kramer MF; Ostertag P; Pfrogner E; Rasp G
    Laryngoscope; 2000 Jun; 110(6):1056-62. PubMed ID: 10852530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum leptin levels in patients with pollen-induced allergic rhinitis.
    Ciprandi G; Filaci G; Negrini S; De Amici M; Fenoglio D; Marseglia G
    Int Arch Allergy Immunol; 2009; 148(3):211-8. PubMed ID: 18849612
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibitory action of levocetirizine on the production of eosinophil chemoattractants RANTES and eotaxin in vitro and in vivo.
    Kanei A; Asano K; Kanai K; Furuta A; Sasaki K; Suzaki H
    In Vivo; 2014; 28(4):657-66. PubMed ID: 24982238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils.
    Matsunaga Y; Kido H; Kawaji K; Kamoshita K; Katunuma N; Ogura T
    Arch Biochem Biophys; 1994 Jul; 312(1):67-74. PubMed ID: 8031148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Taurine chloramine inhibits functional responses of human eosinophils in vitro.
    Martinez-Losa M; Cortijo J; Piqueras L; Sanz MJ; Morcillo EJ
    Clin Exp Allergy; 2009 Apr; 39(4):537-46. PubMed ID: 19222497
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of T-cell function by (R)- and (S)-isomers of albuterol: anti-inflammatory influences of (R)-isomers are negated in the presence of the (S)-isomer.
    Baramki D; Koester J; Anderson AJ; Borish L
    J Allergy Clin Immunol; 2002 Mar; 109(3):449-54. PubMed ID: 11897990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Letter: Effect of beta stimulant on eosinopenic responses.
    Gayrard P
    J Allergy Clin Immunol; 1973 Nov; 52(5):319. PubMed ID: 4355736
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria.
    Winkelmann RR; Kim GK; Del Rosso JQ
    J Clin Aesthet Dermatol; 2013 Jan; 6(1):27-38. PubMed ID: 23320123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-inflammatory and antinociceptive effects of salbutamol on acute and chronic models of inflammation in rats: involvement of an antioxidant mechanism.
    Uzkeser H; Cadirci E; Halici Z; Odabasoglu F; Polat B; Yuksel TN; Ozaltin S; Atalay F
    Mediators Inflamm; 2012; 2012():438912. PubMed ID: 22665951
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Racemic salbutamol and levosalbutamol in mild persistent asthma: A comparative study of efficacy and safety.
    Maiti R; Prasad CN; Jaida J; Mukkisa S; Koyagura N; Palani A
    Indian J Pharmacol; 2011 Nov; 43(6):638-43. PubMed ID: 22144765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Levalbuterol versus albuterol.
    Ameredes BT; Calhoun WJ
    Curr Allergy Asthma Rep; 2009 Sep; 9(5):401-9. PubMed ID: 19671384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. (R)-albuterol decreases immune responses: role of activated T cells.
    Ferrada MA; Gordon EL; Jen KY; He HZ; Lu X; Barone LM; Amirifeli S; Perkins DL; Finn PW
    Respir Res; 2008 Jan; 9(1):3. PubMed ID: 18194569
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beta2-agonists and bronchial hyperresponsiveness.
    Page CP; Spina D
    Clin Rev Allergy Immunol; 2006; 31(2-3):143-62. PubMed ID: 17085790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Single-isomer levalbuterol: a review of the acute data.
    Nowak R
    Curr Allergy Asthma Rep; 2003 Mar; 3(2):172-8. PubMed ID: 12562558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of adhesion of AML14.3D10 cells by surface clustering of beta2-integrin caused by ERK-independent activation of cPLA2.
    Myou S; Zhu X; Boetticher E; Qin Y; Myo S; Meliton A; Lambertino A; Munoz NM; Hamann KJ; Leff AR
    Immunology; 2002 Sep; 107(1):77-85. PubMed ID: 12225365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of enantiomeric forms of albuterol on stimulated secretion of granular protein from human eosinophils.
    Leff AR; Herrnreiter A; Naclerio RM; Baroody FM; Handley DA; Muñoz NM
    Pulm Pharmacol Ther; 1997; 10(2):97-104. PubMed ID: 9425641
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beta adrenergic modulation of formyl-methionine-leucine-phenylalanine-stimulated secretion of eosinophil peroxidase and leukotriene C4.
    Munoz NM; Vita AJ; Neeley SP; McAllister K; Spaethe SM; White SR; Leff AR
    J Pharmacol Exp Ther; 1994 Jan; 268(1):139-43. PubMed ID: 8301549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paradoxical blockade of beta adrenergically mediated inhibition of stimulated eosinophil secretion by salmeterol.
    Muñoz NM; Rabe KF; Vita AJ; McAllister K; Mayer D; Weiss M; Leff AR
    J Pharmacol Exp Ther; 1995 May; 273(2):850-4. PubMed ID: 7752089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Augmentation of stimulated eosinophil degranulation by VLA-4 (CD49d)-mediated adhesion to fibronectin.
    Neeley SP; Hamann KJ; Dowling TL; McAllister KT; White SR; Leff AR
    Am J Respir Cell Mol Biol; 1994 Aug; 11(2):206-13. PubMed ID: 8049081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential effects of salbutamol and salmeterol on human eosinophil responses.
    Ezeamuzie CI; al-Hage M
    J Pharmacol Exp Ther; 1998 Jan; 284(1):25-31. PubMed ID: 9435156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.